{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:00:54Z","timestamp":1790694054688,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115246","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:25:11Z","timestamp":1772731511000},"page":"115246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Perfusion microbioreactor for CAR-Treg manufacturing"],"prefix":"10.1016","volume":"29","author":[{"given":"William","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Mastronicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Scott\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare M.","family":"Cejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Espinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Chiappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115246_bib1","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2017-02-769208","article-title":"Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults","volume":"129","author":"Gardner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.isci.2026.115246_bib2","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.3389\/fimmu.2020.01608","article-title":"The Future of Regulatory T Cell Therapy: Promises and Challenges of Implementing CAR Technology","volume":"11","author":"Mohseni","year":"2020","journal-title":"Front. Immunol. Frontiers Media S.A."},{"key":"10.1016\/j.isci.2026.115246_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.isci.2026.115246_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.115246_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/ajt.14175","article-title":"Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor","volume":"17","author":"Noyan","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.isci.2026.115246_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.ekir.2022.03.030","article-title":"Study Design: Human Leukocyte Antigen Class I Molecule A\u221702-Chimeric Antigen Receptor Regulatory T Cells in Renal Transplantation","volume":"7","author":"Schreeb","year":"2022","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.isci.2026.115246_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41434-022-00358-x","article-title":"Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation","volume":"30","author":"Proics","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.isci.2026.115246_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.115246_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41409-022-01866-5","article-title":"Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy\u00ae: real-world experience and cost analysis in India","volume":"58","author":"Palani","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.isci.2026.115246_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2019.00038","article-title":"Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System","volume":"10","author":"Mar\u00edn Morales","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.isci.2026.115246_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/08830185.2022.2067154","article-title":"Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies","volume":"41","author":"Song","year":"2022","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.isci.2026.115246_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00482","article-title":"Point-of-care CAR T-cell production (ARI-0001) using a closed semi-automatic bioreactor: Experience from an academic phase i clinical trial","volume":"11","author":"Castella","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.isci.2026.115246_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73755-0","article-title":"High-throughput continuous-flow microfluidic electroporation of mRNA into primary human T cells for applications in cellular therapy manufacturing","volume":"10","author":"Lissandrello","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115246_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jcyt.2024.08.009","article-title":"Bioreactor on a chip: a microfluidic device for closed production of human dendritic cells","volume":"27","author":"Loutherback","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.isci.2026.115246_bib15","doi-asserted-by":"crossref","first-page":"15101","DOI":"10.1038\/s41598-019-50981-9","article-title":"A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies","volume":"9","author":"Moore","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.115246_bib16","doi-asserted-by":"crossref","first-page":"e2101018","DOI":"10.1002\/adbi.202101018","article-title":"Inertial Microfluidic Purification of CAR-T-Cell Products","volume":"6","author":"Elsemary","year":"2022","journal-title":"Adv. Biol."},{"key":"10.1016\/j.isci.2026.115246_bib17","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1039\/D3LC00622K","article-title":"Expanding CAR-T cell immunotherapy horizons through microfluidics","volume":"24","author":"Kim","year":"2024","journal-title":"Lab Chip"},{"key":"10.1016\/j.isci.2026.115246_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41551-024-01315-2","article-title":"Microfluidic technologies for enhancing the potency, predictability and affordability of adoptive cell therapies","volume":"9","author":"Wang","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.isci.2026.115246_bib19","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41551-024-01219-1","article-title":"A high-density microfluidic bioreactor for the automated manufacturing of CAR T cells","volume":"8","author":"Sin","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.isci.2026.115246_bib27","doi-asserted-by":"crossref","first-page":"101600","DOI":"10.1016\/j.omtm.2025.101600","article-title":"Lactic acid improves Treg manufacturing and in vivo function","volume":"33","author":"Tuomela","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.isci.2026.115246_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.omtm.2021.02.002","article-title":"Enriching leukapheresis improves T cell activation and transduction efficiency during CAR T processing","volume":"20","author":"Noaks","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.isci.2026.115246_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/stem.150162","article-title":"Retroviral Stem Cell Gene Therapy","volume":"15","author":"Havenga","year":"1997","journal-title":"Stem Cell."},{"key":"10.1016\/j.isci.2026.115246_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/bs.pmbts.2014.10.012","article-title":"Molecular Determinants of the Ratio of Inert to Infectious Virus Particles","volume":"129","author":"Klasse","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.isci.2026.115246_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/cmi.2013.33","article-title":"Full screening and accurate subtyping of HLA-A \u2217 02 alleles through group-specific amplification and mono-allelic sequencing","volume":"10","author":"Song","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.115246_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12967-025-06561-9","article-title":"Clinical grade expansion protocol for the manufacture of thymus-derived Treg cells for clinical application","volume":"23","author":"Fanelli","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.isci.2026.115246_bib25","article-title":"Intermediate layer-based bonding techniques for polydimethylsiloxane\/digital light processing 3D-printed microfluidic devices","volume":"29","author":"Cheon","year":"2019","journal-title":"JMiMi"},{"key":"10.1016\/j.isci.2026.115246_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-0716-2376-3_9","article-title":"CellTraceTM Violet Flow Cytometric Assay to Assess Cell Proliferation","volume":"2508","author":"Lemieszek","year":"2022","journal-title":"Methods Mol. Biol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226006218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226006218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:36:22Z","timestamp":1790692582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226006218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226006218"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115246","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perfusion microbioreactor for CAR-Treg manufacturing","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115246"}}